Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DX3-213B

DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM. DX3-213B blocks ATP production (IC50: 11 nM) and inhibits the growth of MIA PaCa-2 cells (GI50: 11 nM) . DX3-213B can be used to study pancreatic cancer.

Product Specifications

CAS Number

2749555-66-4

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

478.57

Molecular Formula

C20H28F2N2O5S2

Notes

Research use only, not for human use.

Receptor

OXPHOS

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

STAU1 Blocking Peptide
33R-7376 0.1 mg

STAU1 Blocking Peptide

Sign In for Pricing
View Details
Lactalbumin hydrolysate soluble
L00040-01 500 g

Lactalbumin hydrolysate soluble

Sign In for Pricing
View Details
Lactalbumin hydrolysate soluble
L00040-02 1000 g

Lactalbumin hydrolysate soluble

Sign In for Pricing
View Details
Lactalbumin hydrolysate soluble
L00040-03 5000 g

Lactalbumin hydrolysate soluble

Sign In for Pricing
View Details
Mouse Slc22a3 Pre-designed siRNA Set B
SI113062B 1 Each

Mouse Slc22a3 Pre-designed siRNA Set B

Sign In for Pricing
View Details
FCER1A (High Affinity Immunoglobulin epsilon Receptor Subunit alpha, Fc-epsilon RI-alpha, FcERI, IgE Fc Receptor Subunit alpha, FCE1A) (MaxLight 750) discontinued
126719-ML750 100 µL

FCER1A (High Affinity Immunoglobulin epsilon Receptor Subunit alpha, Fc-epsilon RI-alpha, FcERI, IgE Fc Receptor Subunit alpha, FCE1A) (MaxLight 750) discontinued

Sign In for Pricing
View Details